50% off Premium Yearly
He likes their model, and there is no demand for their products.
Stock price when the opinion was issued
As of Jun 12, 2026. Market Open.
Speculative, but we need more pharma companies to make immunotherapy drugs.
Build your watch list
Sign in to track investmentsyou care about
CNBC
RN Croft Financial Group
5i Research
Stockchase Premium
Private Wealth Management, ScotiaMcleod
He likes their model, and there is no demand for their products.